Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q2

6523.TEDINET S100PICM
Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥170.6bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥89.1bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥340.5bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥166.1bn2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥85.1bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥10.5bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥8.5bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥13.5bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥7.9bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥3.4bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥9.7bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥3.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥20.1bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥6.0bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥1.2bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥8.3bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥8.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥15.0bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥4.6bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥1.4bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥8.5bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥15.1bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥4.6bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥596.3bnat 2022-09-30Cons.Assets IFRS
Total assets¥591.3bnat 2022-03-31Cons.Assets IFRS
Total assets¥569.2bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥446.9bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥455.3bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥149.3bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥124.1bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥107.6bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥148.3bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥135.4bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥123.5bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥73.7bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥59.6bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.8bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥5.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥51.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥20.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥8.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥12.5bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥6.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥20.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥7.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥14.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥9.612022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥66.62022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥-70.782021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥129.062021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥39.672021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥9.522022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥65.982022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-70.782021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥125.012021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥38.422021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio24.9%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio22.9%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio21.7%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30¥1.1bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-09-30¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥9.4bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-09-30¥55.4bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-09-30¥55.4bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-09-30¥12.0bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-09-30¥49.3bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-09-30¥49.3bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.7bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-09-30¥64.8bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-09-30¥64.8bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.3bn
—segment totalrevenue2022-04-01 → 2022-09-30¥169.5bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥169.5bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥20.0bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30¥1.4bn
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2021-09-30¥1.4bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥8.8bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue2021-04-01 → 2021-09-30¥53.7bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue external2021-04-01 → 2021-09-30¥53.7bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentsegment profit2021-04-01 → 2021-09-30¥10.5bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2021-04-01 → 2021-09-30¥44.0bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2021-04-01 → 2021-09-30¥44.0bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2021-04-01 → 2021-09-30¥3.0bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue2021-04-01 → 2021-09-30¥66.9bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue external2021-04-01 → 2021-09-30¥66.9bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentsegment profit2021-04-01 → 2021-09-30¥8.8bn
—segment totalrevenue2021-04-01 → 2021-09-30¥164.6bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥164.6bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥22.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 976
ItemContextValueUnit
Inventories ca IFRSCurrentQuarterInstant52066000000JPY
Other financial assets ca IFRSPrior1YearInstant2393000000JPY
Other financial assets ca IFRSCurrentQuarterInstant2477000000JPY
Other current assets ca IFRSPrior1YearInstant10498000000JPY
Other current assets ca IFRSCurrentQuarterInstant12091000000JPY
Current assets IFRSPrior1YearInstant216361000000JPY
Current assets IFRSCurrentQuarterInstant202940000000JPY
Property plant and equipment IFRSPrior1YearInstant48276000000JPY
Property plant and equipment IFRSCurrentQuarterInstant49079000000JPY
Goodwill IFRSPrior1YearInstant197754000000JPY
Goodwill IFRSCurrentQuarterInstant214217000000JPY
Intangible assets IFRSPrior1YearInstant99139000000JPY
Intangible assets IFRSCurrentQuarterInstant100231000000JPY
Investments accounted for using equity method IFRSPrior1YearInstant3484000000JPY
Investments accounted for using equity method IFRSCurrentQuarterInstant3618000000JPY
Other financial assets nca IFRSPrior1YearInstant22257000000JPY
Other financial assets nca IFRSCurrentQuarterInstant19924000000JPY
Deferred tax assets IFRSPrior1YearInstant3245000000JPY
Deferred tax assets IFRSCurrentQuarterInstant4757000000JPY
Other non current assets nca IFRSPrior1YearInstant802000000JPY
Other non current assets nca IFRSCurrentQuarterInstant1511000000JPY
Non current assets IFRSPrior1YearInstant374959000000JPY
Non current assets IFRSCurrentQuarterInstant393340000000JPY
Assets IFRSPrior1YearInstant591320000000JPY
Assets IFRSCurrentQuarterInstant596280000000JPY
Trade and other payables cl IFRSPrior1YearInstant68802000000JPY
Trade and other payables cl IFRSCurrentQuarterInstant64853000000JPY
Borrowings cl IFRSPrior1YearInstant27251000000JPY
Borrowings cl IFRSCurrentQuarterInstant30780000000JPY
Income taxes payable cl IFRSPrior1YearInstant3219000000JPY
Income taxes payable cl IFRSCurrentQuarterInstant5345000000JPY
Provisions cl IFRSPrior1YearInstant5019000000JPY
Provisions cl IFRSCurrentQuarterInstant4680000000JPY
Other financial liabilities cl IFRSPrior1YearInstant5707000000JPY
Other financial liabilities cl IFRSCurrentQuarterInstant6538000000JPY
Other current liabilities cl IFRSPrior1YearInstant27745000000JPY
Other current liabilities cl IFRSCurrentQuarterInstant20116000000JPY
Total current liabilities IFRSPrior1YearInstant137745000000JPY
Total current liabilities IFRSCurrentQuarterInstant132314000000JPY
Trade and other payables ncl IFRSPrior1YearInstant1942000000JPY
Trade and other payables ncl IFRSCurrentQuarterInstant1905000000JPY
Borrowings ncl IFRSPrior1YearInstant280685000000JPY
Borrowings ncl IFRSCurrentQuarterInstant278846000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant8214000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant7627000000JPY
Provisions ncl IFRSPrior1YearInstant3277000000JPY
Provisions ncl IFRSCurrentQuarterInstant3455000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant10076000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant9780000000JPY
Deferred tax liabilities IFRSPrior1YearInstant11789000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass